Biotechnology Assets, S.A. (BST:041)

Germany flag Germany · Delayed Price · Currency is EUR
0.4450
-0.0030 (-0.67%)
At close: Jul 24, 2025
-0.67%
Market Cap25.51M
Revenue (ttm)2.97M
Net Income (ttm)-2.92M
Shares Outn/a
EPS (ttm)-0.04
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume29,250
Average Volume10,515
Open0.2680
Previous Close0.4480
Day's Range0.2680 - 0.4470
52-Week Range0.1504 - 0.5240
Betan/a
RSI55.99
Earnings Daten/a

About Biotechnology Assets

Biotechnology Assets, S.A. develops and markets biotechnological assets for application in the biopharmaceutical, agrochemical, cosmetic, veterinary, and chemical industry sectors in Spain and internationally. It offers SPLITTERA technology an innovative, universal and robust solution for site-specific conjugation of proteins. Biotechnology Assets, S.A. is based in Cádiz, Spain. [Read more]

Industry Pharmaceutical Preparations
CEO Jaime Feced Rubio
Employees 34
Stock Exchange Stuttgart Stock Exchange
Ticker Symbol 041
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.